Published in Hepatitis Weekly, November 15th, 1999
In this randomized, controlled trial, researcher M.L. Shiffman and colleagues looked into whether maintenance interferon therapy could prevent histological progression in this subset of nonresponders ("A Randomized, Controlled Trial of Maintenance Interferon Therapy for Patients with Chronic Hepatitis C Virus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly